Koninklijke DSM NV
OTC:KDSKF
Intrinsic Value
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. [ Read More ]
The intrinsic value of one
KDSKF
stock under the Base Case scenario is
1 245.73
USD.
Compared to the current market price of 43.02 USD,
Koninklijke DSM NV
is
Undervalued by 97%.
DSM could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Koninklijke DSM NV's market capitalization is 568.6m EUR.
KDSKF stock price is 43.02 USD.
KDSKF stock price (43.02 USD) is 97% less than its Intrinsic Value (1 245.73 USD).
KDSKF stock price (43.02 USD) is 92% less than its Relative Value (550.74 USD). Open Relative Valuation
KDSKF has upside potential of 280% compared to the average analyst price target.
Open Wall St Estimates
KDSKF's ROIC (Return on Invested Capital) has decreased in the last 3 years from 5% to 4%.
KDSKF has positive Operating Income for the last twelve months.
KDSKF has positive three-year average ROE (Return on Equity): 11%. The company is efficient at transforming stockholders' equity into net income.
KDSKF has positive Net Income for the last twelve months.
KDSKF has positive Gross Profit for the last twelve months.
KDSKF's Revenue has grown by 15% over the past 12 months.
KDSKF's ROE (Return on Equity) for the past 12 months is positive and is equal to 17%.
KDSKF's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
KDSKF has positive Net Debt. This means that the company has more debt (3B EUR) than cash and short-term investments (3B EUR).
KDSKF's ROE (Return on Equity) has significantly increased in the last 3 years from 7% to 17%.
KDSKF has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
KDSKF has positive Free Cash Flow for the last twelve months.
KDSKF earns more than enough operating income (682m EUR) to safely cover interest payments on its debt (52m EUR).
KDSKF's long-term assets (17B EUR) exceed its long-term liabilties (7B EUR).
KDSKF's short-term assets (8B EUR) exceed its short-term liabilties (3B EUR).
KDSKF's D/E (Debt to Equity) is very low and is equal to 0.28.
KDSKF's Altman Z-Score is very low and is equal to 0.85.
Fundamental Analysis
Koninklijke DSM NV
Balance Sheet Decomposition
Koninklijke DSM NV
| Current Assets | 8.1B |
| Cash & Short-Term Investments | 2.9B |
| Receivables | 1.6B |
| Other Current Assets | 3.6B |
| Non-Current Assets | 9.3B |
| Long-Term Investments | 356m |
| PP&E | 3.6B |
| Intangibles | 5.1B |
| Other Non-Current Assets | 196m |
| Current Liabilities | 2.6B |
| Accounts Payable | 1.4B |
| Accrued Liabilities | 22m |
| Other Current Liabilities | 1.1B |
| Non-Current Liabilities | 4.1B |
| Long-Term Debt | 3B |
| Other Non-Current Liabilities | 1.1B |
Earnings Waterfall
Koninklijke DSM NV
|
Revenue
|
8.4B
EUR
|
|
Cost of Revenue
|
-5.7B
EUR
|
|
Gross Profit
|
2.7B
EUR
|
|
Operating Expenses
|
-2B
EUR
|
|
Operating Income
|
682m
EUR
|
|
Other Expenses
|
1B
EUR
|
|
Net Income
|
1.7B
EUR
|
Free Cash Flow Analysis
Koninklijke DSM NV
KDSKF Profitability Score
Profitability Due Diligence
Koninklijke DSM NV's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Koninklijke DSM NV's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
KDSKF Solvency Score
Solvency Due Diligence
Koninklijke DSM NV's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Koninklijke DSM NV's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KDSKF Price Targets Summary
Koninklijke DSM NV
According to Wall Street analysts, the average 1-year price target for
KDSKF
is 163.35 USD
.
Shareholder Return
DSM Price
Koninklijke DSM NV
| Average Annual Return | 27.75% |
| Standard Deviation of Annual Returns | 10.12% |
| Max Drawdown | -45% |
| Market Capitalization | 568.6m EUR |
| Shares Outstanding | 4 985 848 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Koninklijke DSM NV
Country
Industry
Market Cap
Dividend Yield
Description
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
You don't have any saved screeners yet
